We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Siemens’ PETNET Solutions Signs Agreement with Novation for PET Radiopharmaceuticals

By HospiMedica International staff writers
Posted on 13 Aug 2012
PETNET Solutions, Inc. More...
(Knoxville, TN, USA), a wholly owned subsidiary of Siemens Medical Solutions USA, Inc. (Malvern, PA, USA), reported on the signing of a five-year agreement with Novation (Irving, TX, USA;), a healthcare supply chain expertise and contracting company, to offer its range of positron emission tomography (PET) radiopharmaceutical agents for oncology, cardiology, and neurology to healthcare facilities in the United States. Novation provides sourcing services, as well as data services, to a wide range of US healthcare providers.

Siemens’ PETNET Solutions operates the world’s largest network of integrated US Food and Drug Administration (FDA)-registered and state-licensed PET radiopharmaceutical manufacturing and radiopharmacy facilities, with over 50 locations worldwide. Siemens’ PETNET Solutions manufactures and dispenses PET radiopharmaceuticals for hospitals, clinics, and research facilities. With this new five-year agreement, Siemens’ PETNET Solutions will offer the members served by Novation the largest selection of PET radiopharmaceuticals from a single radiopharmaceutical supplier for oncology, cardiology, and neurology.

“Siemens’ PETNET Solutions is pleased to continue our relationship with Novation by providing the healthcare organization it serves with our PET radiopharmaceuticals--proprietary and generic--for clinical use in the United States. The use of these radiopharmaceuticals, in addition to all other PETNET Solutions services, will help ensure that Novation customers remain at the forefront of PET imaging,” said Dr. Christoph Zindel, CEO, PETNET Solutions.

Novation is a leading healthcare supply-chain expertise and contracting company for the more than 65,000 members of the VHA, Inc. (Irving, TX, USA) and United Healthcare (UHC; Minneapolis, MN, USA), two US healthcare alliances, and Provista, LLC (Irving, TX, USA). Novation provides alliance members with sourcing services, as well as information and data services.

The Siemens Healthcare Sector is one of the world’s largest suppliers to the healthcare industry and is focused in medical imaging, laboratory diagnostics, medical information technology (IT), and hearing aids.

Related Links:

PETNET Solutions
Siemens Medical Solutions USA
Novation



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
Rapid Sepsis Test
SeptiCyte RAPID
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image Cedit: Shutterstock

New Light-Activated Platform Advances Glioblastoma Surgery and Postoperative Treatment

Glioblastoma, an aggressive primary brain tumor, infiltrates healthy tissue and resists complete surgical removal. Residual microscopic disease and the blood–brain barrier limit the effectiveness of adjuvant... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.